I did consider those statistics you quote there regarding the deaths. I don’t think there was a message in the presentation that it was failing though. I believe he pointed out pre-treated issues, which he did not have time to explain properly. It was a very short update with such little time. I could tell that given the opportunity, the intricacies and specifics would have given a much more detailed look at the whole situation. My take on it was overall, there is much optimism in the overall effectiveness of Azercel, and further studies are ongoing. I think GMT said it best. Seeking further clarification from IMU directly is the only real way to address concerns.
I still remain confident overall and have no intention of parting with shares. I believe it is much too early and I’m happy to wait for more detailed data and explanation of that data. Apart from out and out negativity and down ramping, I like the thoughts and ideas put forward here on HC. GLTAH.
IMU Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
